Date: 25th October, 2021
Time: 11:00am CEST/GMT+2
Nowadays, mAb CMC development is becoming more and more standardized. However, there is still no standardized CMC strategy for recombinant protein production, thus requiring formation of customized CMC strategies for each use case.
Customized CMC strategies should be developed according to the molecular features of the mAb desired. GenScript ProBio has delivered several recombinant protein CMC orders and has helped clients on their way to IND approvals.
In this webinar, Senior Project Manager Dr. Leon Tian will detail GenScript ProBio’s experience and understanding in dealing with recombinant protein challenges, and how ProBio can help clients develop a unique, customized CMC strategy to achieve their goals.